The editors of Current Biology really should be more careful; some contributors are in danger of giving the game away. Years of careful fostering of the idea that everything can be explained in terms of molecular genetics and structural biology -thus keeping many of us gainfully employed -may have been undermined by their careless revelations. The current ascendancy of these disciplines could be at risk if information so casually made available should fall into the wrong hands.
Usually, you play your role exceptionally well. Unqualified assertions that genetic studies of aggressiveness in mice could ". . . be directly applicable to our understanding of human nature" slipped into the literature without a ripple [1] . Sydney Brenner's suggestion that, because some viral gene products combine in a fixed proportion, "it is possible to encode a mathematical rule in DNA" [2] with the logical extrapolation that if he, a mere bundle of gene products, jumped out of the window, his DNA would implicitly encode the law of gravity -gave genome studies the opportunity to annex half the funds for chemical and physical research. Then there was the statement about the yeast genome, worthy of a Star Trek script, ". . . it encourages us to pursue the goal that has been implicit from the beginning: the complete understanding of how a eukaryotic cell functions. The attainment of this lofty goal now seems possible" [3] .
Virtual biology and surfing the genomes was all set to abolish the need for messy, wet experiments, which don't always work and, when they do, have a regrettable tendency to throw up untidy, unexpected results. Many of us were looking forward to seeing out our entire research careers with a few clicks on the mouse and a sheaf of publications liberally seeded with comments such as 'intriguing conserved sequence motif', 'could suggest', 'might imply' and (my favourite) 'putative receptor'.
But, just when half the world was convinced that every problem from constipation to criminality is rooted in the base sequence of DNA, you allow loose talk such as ". . . almost any protein domain can bind inositol phosphate if required" [4] to slip through. Furthermore, the authors openly admit to ". . . the variety of domains that can bind inositol phosphates", and make things even worse by conceding that ". . . the functions of most of the binding sites are not yet clear".
Every research scientist using low molecular weight, biologically active compounds soon becomes aware that almost any protein domain can bind almost anything under the right circumstances, but most are instinctively discreet about it. If the promiscuous tendencies of proteins and the sheer variability of biological systems became widely appreciated, ignorant, unscrupulous journalists could call into question our ability to predict the behaviour of living systems from their DNA sequences and protein structures. The fig-leaf of a priori reasoning could be shamelessly stripped away to reveal vulgar post hoc rationalization.
We can only hope that the relaxed style of Current Biology and the speculative license it allows to its contributors have not attracted critical readers from outside the profession.
Warthog and Groundhog, novel families related to Hedgehog Thomas R. Bürglin
Cell-cell signalling is one of the fundamental mechanisms by which different cell fates are generated during development. One group of signalling molecules, encoded by the Drosophila gene hedgehog and its vertebrate orthologues, has been shown to play important roles during development of flies and vertebrates (see [1] [2] [3] ). Searching through the Caenorhabditis elegans genome, a major fraction of which has now been sequenced [4] , reveals several sequences with similarities to hedgehog genes. The similarity is restricted to the carboxyl terminus of the Hedgehog proteins, which is surprising given that the aminoterminal part, which provides the biologically active signal, is more highly conserved between fly and vertebrate Hedgehogs. The carboxyl terminus is a distinct domain that has autoproteolytic activity and cleaves Hedgehog into a protease domain and a signalling part [5] [6] [7] , and it is thought to regulate the release of the amino-terminal signal (see [8] ).
The carboxy-terminal domain, which I refer to here as the 'Hog' domain, is about 200-250 amino acids long. Figures 1 and 2a show an alignment of the Hog domains of various Hedgehogs from flies and vertebrates, as well as the predicted products of several of the new C. elegans genes. The level of sequence similarity between the C. elegans and Hedgehog sequences is of the order of 22-32 % identity in this domain, with highly significant scores produced by BLAST database searches [9] . The probability of a chance match of the ZK678 Hog domain to Drosophila Hedgehog is 4.2 × 10 -7 . A search of Genbank with the Hog domain has not revealed any other genes encoding this domain.
The autoproteolytic cleavage site in Hedgehog is at a conserved Cys-Phe pair (see arrow, Fig. 2a ) within the Hog domain [5] , and these two residues are conserved in the C. elegans Hog domains. The cleavage site was also predicted by computer comparison to the aminoterminal splice sites of 'intein' protein domains, which are spliced out of larger precursor proteins [10] ; the N′-terminal splice junction motif for intein proteins (block A, Fig. 2a ) matches all Hog domains. A second weak similarity to intein sequence block B [11] is also observed in the Hog domain (Fig. 2a) , but the rest of the Hog domain has no further similarity with inteins.
Novel domains associated with Hog
As the Hog domain is located at the carboxyl terminus (Fig. 1) , database searches and comparisons were performed using the amino-terminal parts of the same sequences; these revealed two new motifs. The first, of about 130-170 amino acids, for which I propose the name 'Wart', is present in eight C. elegans sequences (Fig. 2b) . There appear to be two different types of Wart domain that differ in their central region. Most sequences with a Wart domain also have an associated Hog domain, but three have not (Fig.  1) . The Wart domains are highly divergent, but their similarity is nevertheless statistically significant. Their high divergence allows the identification of crucial residues: cysteines appear to play an important role (Fig. 2b) . All Warthog sequences have good signal sequences [12] (for protein export) immediately upstream of the Wart domain (Figs 1, 2b) .
The second motif, for which I propose the name 'Ground', is found in nine C. elegans sequences and one from the parasitic nematode Brugia malayi ( Most of the genes presented here must be functional, as cDNAs have been found for several of them. Because the Hog domain has so far always been found at the carboxyl terminus of a sequence ( Fig. 1) , it seems unlikely that any protein splicing is involved. The Hog domain might play a role in regulating the release of the aminoterminal signal domain, but several of the Warthogs and Groundhogs do not have a Hog domain, suggesting that it is not always required, and that its putative regulatory role is dispensable under certain conditions.
The fact that most, if not all, of the sequences have a leader motif indicates that they are secreted molecules. In flies and vertebrates, the Hog domain has so far been found only in the Hedgehog proteins, which are involved in cell-cell signalling. The Wart and the Ground domains are both relatively small motifs The structure of Hedgehog proteins, the C. elegans and B. malayi Hog, Warthog and Groundhog proteins. The open reading frames (ORFs) used in Fig. 2 were either taken as annotated by the Genome Project or analyzed using Genefinder in ACEDB locally [17] . Local ORF analysis, taking into account the observed sequence similarities, occasionally yielded results different from the annotations by the Genome Project (such ORFs are in quotation marks). In two cases, other genes are inappropriately joined to Warthog genes (ZK1290.5, an aldo/keto reductase, and F38E4.6, a cGMP cation-gated channel protein). In some cases (F46H5 and C04E6) the precise 5′ end could not be determined conclusively. For W06B11.4 the start codon is predicted to be inside the Hog domain; the highly conserved Cys-Phe of the protein splice junction in Fig. 2a © 1996 Current Biology characterized by conserved cysteines, reminiscent of other signalling molecules, such as the activin/TGF-␤ family [13] , the NGF-type growth factors [14] , the Wnt family [15] , and the chordin family [16] . Thus it is possible that the new Hog family members are novel signalling molecules. A member has already been found in a divergent nematode species, so others might occur in flies and vertebrates too. It seems likely . Phase II trials of p24-VLP, a "virus-like-particle" and candidate HIV therapeutic vaccine, proved "less than encouraging" and were dropped.
How is the company funded?
Mostly by stock sales; there is no income from drugs as yet. It recently launched a rights issue to raise £143 million (about $212 million), thought to be the largest amount ever raised by a biotech company. Less than half of the shares were taken up by existing shareholders, however; this was disappointing, but not fatal, as underwriters made up the difference.
Why did it need to raise more money?
Although British Biotech's cash reserves stood at around £66 million before the rights issue, the company plans extensive (and expensive) clinical trials for both of its lead products in the near future. The company claims that this should be the last time it needs to appeal to the stock market for cash before the money from hoped-for drug sales starts coming in. The company also wants to consolidate its UK operations at a new site in Cowley, Oxford.
Does the company have any presence
in the US? Yes. British Biotech Inc. was founded in 1993 in Annapolis. It's responsible for clinical trials in the US, and for dealing with the US Food and Drug Administration.
Why are there so few biotechnology companies in the UK? British Biotech's success in raising money suggests that the problem is not one of funding. The lack of entrepreneurial spirit in the 'old country' is a popular explanation, as always; the fact that venture capitalists are less aggressive outside the US may also be a factor.
